Lazard Asset Management
HCAT icon

Lazard Asset Management’s Health Catalyst HCAT Stock Holding History

Lazard Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-81,537
Closed -$307K – 2031
2025
Q2 		$307K Sell
81,537
-5,989
-7% -$23.6K ﹤0.01% 1616
2025
Q1 		$396K Sell
87,526
-10,030
-10% -$53.1K ﹤0.01% 1471
2024
Q4 		$689K Sell
97,556
-113,721
-54% -$906K ﹤0.01% 1272
2024
Q3 		$1.72M Sell
211,277
-29,903
-12% -$216K ﹤0.01% 904
2024
Q2 		$1.54M Sell
241,180
-27,857
-10% -$179K ﹤0.01% 889
2024
Q1 		$2.02M Sell
269,037
-24,148
-8% -$220K ﹤0.01% 826
2023
Q4 		$2.71M Sell
293,185
-12,001
-4% -$98.1K ﹤0.01% 797
2023
Q3 		$3.09M Sell
305,186
-9,124
-3% -$109K ﹤0.01% 800
2023
Q2 		$3.93M Sell
314,310
-18,757
-6% -$223K ﹤0.01% 756
2023
Q1 		$3.89M Buy
333,067
+11,185
+3% +$143K 0.01% 779
2022
Q4 		$3.42M Sell
321,882
-256,719
-44% -$2.48M ﹤0.01% 798
2022
Q3 		$5.61M Buy
578,601
+89,046
+18% +$1.18M 0.01% 684
2022
Q2 		$7.09M Buy
489,555
+117,099
+31% +$2M 0.01% 662
2022
Q1 		$9.73M Buy
372,456
+52,057
+16% +$1.48M 0.01% 625
2021
Q4 		$12.7M Buy
320,399
+242,478
+311% +$11.1M 0.01% 577
2021
Q3 		$3.9M Buy
77,921
+3,659
+5% +$200K ﹤0.01% 807
2021
Q2 		$4.12M Buy
74,262
+49,276
+197% +$2.63M ﹤0.01% 750
2021
Q1 		$1.17M Buy
24,986
+6,224
+33% +$301K ﹤0.01% 880
2020
Q4 		$816K Buy
+18,762
New +$692K ﹤0.01% 918

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Lazard Asset Management's HCAT Position: Q3 2025 in Review

Lazard Asset Management sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 81,537 shares — an estimated $307K sold.

Lazard Asset Management first reported a position in HCAT in Q4 2020 and held it in 19 quarters. The position peaked at $12.7M in Q4 2021. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Lazard Asset Management reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 81,537 Health Catalyst shares in Q3 2025, an estimated $307K.
  • Lazard Asset Management first reported a position in Health Catalyst in Q4 2020 and held it in 19 quarters.
  • Lazard Asset Management's Health Catalyst position peaked at $12.7M in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.